Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
KRAS G12S
Cancer:
Colorectal Cancer
Drug:
sunitinib
(
c-KIT inhibitor
,
VEGFR inhibitor
,
PDGFR inhibitor
)
Direction:
Resistant
Evidence:
Evidence Level:
Resistant: D – Preclinical
New
Source:
J Cancer Res Clin Oncol
Title:
KRAS allel-specific activity of sunitinib in an isogenic disease model of colorectal cancer
Excerpt:
In the MTT chemosensitivity assay, the grade of resistance was less pronounced in G13D and highest in G12A, G12C, and G12S mutant cells.
DOI:
10.1007/s00432-013-1401-9
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.